Elucidating the Role of YAP and TAZ in the Aging Human Ovary
阐明 YAP 和 TAZ 在人类卵巢衰老中的作用
基本信息
- 批准号:10722368
- 负责人:
- 金额:$ 42.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-07 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAddressAffectAgeAgingArchitectureAutomobile DrivingBindingBiochemicalBioinformaticsCandidate Disease GeneCategoriesCattleCell CycleCell Fate ControlCell LineCell ProliferationCell physiologyChildbirthChromatinClinicalCommunicationComplexContraceptive methodsDNADataDevelopmentDiagnosisDown-RegulationEducationElderlyEndocrineEnzymesEstrogensEventFemale infertilityFertilityFertilization in VitroFollicle Stimulating HormoneGene ExpressionGene Expression ProfilingGenesGeneticGenetic TranscriptionGenomicsGoalsGonadotropinsGrowthHomeostasisHumanInfertilityIrregular MenstruationKnowledgeMediatingMedicalMenopauseMolecularMothersMusNatural FertilityNuclearOccupationsOocytesOrgan SizeOvarianOvarian FollicleOvarian agingOvaryPathway interactionsPatientsPatternPerimenopausePlayPolycystic Ovary SyndromeProceduresProcessProliferatingProteinsProtocols documentationPublishingReportingResearchRoleSamplingSerumSignal PathwaySignal TransductionSmall Interfering RNASocial ChangeSteroid biosynthesisTechniquesTimeTranscriptional RegulationValidationWithdrawalWomanadvanced maternal ageage relatedconnective tissue growth factordiminished ovarian reserveexperiencefertility preservationgain of functiongenetic signaturegranulosa cellhealth disparityimprovedinfertility treatmentinnovationinsightmechanical signalmullerian-inhibiting hormonemultiple omicsnovelnucleaseolder womenoocyte maturationparacrinepatient responseprogramsreproductiveresponsesenescencesocial structuresuccesstranscription factortranscriptometranscriptome sequencingtranscriptomicstrendtumorigenesisyoung woman
项目摘要
PROJECT SUMMARY
Ovarian senescence begins about age 30 and over the next 10 to 15 years is manifested by infertility. An
expanded knowledge of the underlying molecular mechanisms that dictate granulosa cell function will facilitate
our understanding of the health disparities of age and infertility. Over the past half century, the number of first-
time mothers of advanced maternal aged women 35 years and older has increased more than five-fold. With
more women entering the workforce, changes in social structure, advanced education and increased use of
contraception, this trend will likely continue to increase. There is a constant bi-directional communication
between the oocytes and granulosa cells of the follicle, which is required for development and maturation of
high-quality follicles. The Hippo signaling is known to regulate organ size. Our published results established the
role of Hippo signaling, and its downstream effector molecules, YAP and TAZ, as critical regulators of granulosa
cell function and fertility. Notably, our preliminary analysis identified YAP/TAZ activity to be downregulated in
advanced aged women (≥ 40 years) undergoing IVF and having low oocyte yields. We hypothesize that YAP
and TAZ orchestrate crucial transcriptional events that regulate development of high-quality follicles. However,
there is a gap in knowledge in understanding the actual mechanism of how these transcription factors regulate
granulosa cell function, especially in aging women undergoing IVF. The overarching goal of this proposal is to
understand YAP- and TAZ-mediated transcription and chromatin architecture in granulosa cells of women with
advanced age. A drawback of using primary patient granulosa samples are low sample numbers which is a major
roadblock to progress. The major innovation of this proposal is the ability to simultaneous profile chromatin and
transcription regulation in the same patient sample thus providing greater in-depth understanding of the role of
YAP and TAZ transcription factors in granulosa cell function. Our research strategy includes two specific aims.
In Specific Aim 1. We will define the transcriptional targets of YAP and TAZ in granulosa cells by using
CUT&RUN, a micrococal nuclease technique which can isolate specific protein-DNA complexes and distinguish
direct TF binding from low numbers of granulosa cells. Our analysis includes granulosa cells obtained from IVF
patients with poor response (< 6 oocytes retrieved) and good response (> 17 oocytes retrieved) in women of
advanced maternal age (≥ 40 yrs old). We will also employ ATAC-seq to determine chromatin accessibility in
these patient samples. In Aim 2, we will modulate YAP and TAZ in human granulosa cells and define their
resultant transcriptomic profile. Genes identified in this study will be functionally validated by analysis of
granulosa cell proliferation, differentiation, and senescence. These novel insights will help to better understand
age-related decline in fertility and the role of the Hippo signaling pathway effectors YAP and TAZ in the ovary.
项目总结
卵巢衰老大约在30岁左右开始,在接下来的10到15年里表现为不孕不育。一个
扩大对决定颗粒细胞功能的潜在分子机制的了解将有助于
我们对年龄和不孕不育的健康差距的理解。在过去的半个世纪里,第一批-
35岁及以上的高龄产妇的母亲的时间增加了五倍多。使用
更多的妇女进入劳动力大军,社会结构的变化,高等教育和更多地使用
在避孕方面,这一趋势可能会继续增加。有一种持续的双向交流
卵母细胞和卵泡颗粒细胞之间,这是卵泡发育和成熟所必需的
高质量的毛囊。众所周知,河马信号可以调节器官的大小。我们公布的结果确立了
河马信号及其下游效应分子YAP和TAZ作为颗粒细胞关键调节因子的作用
细胞功能和生育能力。值得注意的是,我们的初步分析发现YAP/TAZ活动在
高龄妇女(≥40岁)接受体外受精且卵子产量低。我们假设YAP
和TAZ协调关键的转录事件,调节高质量卵泡的发育。然而,
在了解这些转录因子如何调节的实际机制方面存在着知识空白
颗粒细胞功能,尤其是接受体外受精的老年妇女。这项提议的首要目标是
了解YAP和TAZ介导的卵巢颗粒细胞转录和染色质构筑
年事已高。使用原发患者颗粒样本的一个缺点是样本数量少,这是一个主要的
前进的路障。该方案的主要创新是能够同时对染色质和
在同一患者样本中的转录调节,从而提供了更深入的了解的作用
YAP和TAZ转录因子在颗粒细胞功能中的作用我们的研究策略包括两个具体目标。
在特定的目标1.我们将确定YAP和TAZ在颗粒细胞中的转录靶点
Cut&Run,一种微卡核酸酶技术,可以分离特定的蛋白质-DNA复合体并区分
从少量的颗粒细胞直接结合转铁蛋白。我们的分析包括从试管受精中获得的颗粒细胞
妇女中反应差(取回6个卵母细胞)和良好反应(取回17个卵母细胞)的患者
高龄产妇(≥40岁)。我们还将使用atac-seq来确定染色质在
这些病人样本。在目标2中,我们将在人颗粒细胞中调节YAP和TAZ,并确定它们的
由此产生的转录图谱。这项研究中确定的基因将通过分析
颗粒细胞的增殖、分化和衰老。这些新颖的见解将有助于更好地理解
与年龄相关的生育力下降以及河马信号通路效应器YAP和TAZ在卵巢中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN S DAVIS其他文献
JOHN S DAVIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN S DAVIS', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10360744 - 财政年份:2021
- 资助金额:
$ 42.21万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10512068 - 财政年份:2021
- 资助金额:
$ 42.21万 - 项目类别:
Signals controlling tissues homeostasis in the ovary
控制卵巢组织稳态的信号
- 批准号:
10509395 - 财政年份:2019
- 资助金额:
$ 42.21万 - 项目类别:
Signals controlling tissues homeostasis in the ovary
控制卵巢组织稳态的信号
- 批准号:
9780784 - 财政年份:2019
- 资助金额:
$ 42.21万 - 项目类别:
Signals controlling tissues homeostasis in the ovary
控制卵巢组织稳态的信号
- 批准号:
10421249 - 财政年份:2019
- 资助金额:
$ 42.21万 - 项目类别:
Signals controlling tissues homeostasis in the ovary
控制卵巢组织稳态的信号
- 批准号:
10044408 - 财政年份:2019
- 资助金额:
$ 42.21万 - 项目类别:
Metabolic Events Controlling Ovarian Steroidogenesis
控制卵巢类固醇生成的代谢事件
- 批准号:
9240226 - 财政年份:2017
- 资助金额:
$ 42.21万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 42.21万 - 项目类别:
Research Grant